The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention



      In the present study we aimed to reveal any probable correlation between neutrophil-to-lymphocyte ratio (N/L ratio) and the occurrence of no-reflow, along with assessment of the prognostic value of N/L ratio in patients with ST-segment elevation myocardial infarction (STEMI).


      The N/L ratio stands practically for the balance between neutrophil and lymphocyte counts in the body, which can also be utilized as an index for systemic inflammatory status.


      In our study, we included 204 consecutive patients suffering from STEMI who underwent primary percutaneous coronary intervention (PCI). Patients with STEMI were assigned into distinct tertiles based on their N/L ratios on admission. No-reflow encountered following PCI was evaluated through both angiography [Thrombolysis in Myocardial Infarction (TIMI) flow and myocardial blush grade (MBG)] and electrocardiography (as ST-segment resolution).


      Patients featured with no ST-resolution were documented to have displayed significantly higher N/L ratio on admission compared to those with intermediate or complete ST-segment resolution. The number of the patients characterized with no-reflow, evident both angiographically (TIMI flow ≤2 or TIMI flow 3 with final myocardial bush grade ≤2 after PCI) and electrocardiographically (ST-resolution <30%), was encountered to depict increments throughout successive N/L ratio tertiles. Moreover, the same also held true for three-year mortality rates across the tertile groups (9% vs. 15% vs. 35%, p < 0.01). Multivariable logistic regression analysis disclosed that N/L ratio on admission stood for a significant indicator for long-term mortality in patients with no-reflow phenomenon detected with MBG. Elevated N/L ratio on admission was also found to be a significant indicator for three-year mortality and major adverse cardiac events.


      In patients with STEMI who underwent primary PCI, elevated N/L ratios on admission were revealed to be correlated with both no-reflow phenomenon and long-term prognosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Van de Werf F.
        • Bax J.
        • Betriu A.
        • et al.
        Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
        Eur Heart J. 2008; 29: 2909-2945
        • Rezkalla S.H.
        • Kloner R.A.
        Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.
        Catheter Cardiovasc Interv. 2008; 72: 950-957
        • Zazula A.D.
        • Precoma-Neto D.
        • Gomes A.M.
        • et al.
        An assessment of neutrophils/lymphocytes ratio in patients suspected of acute coronary syndrome.
        Arq Bras Cardiol. 2008; 90: 31-36
        • Horne B.D.
        • Anderson J.L.
        • John J.M.
        • et al.
        Which white blood cell subtypes predict increased cardiovascular risk?.
        J Am Coll Cardiol. 2005; 45: 1638-1643
        • Andersen H.R.
        • Nielsen T.T.
        • Rasmussen K.
        • et al.
        A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
        N Engl J Med. 2003; 349: 733-742
        • Morrow D.A.
        • Antman E.M.
        • Charlesworth A.
        • et al.
        TIMI risk score for ST- elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy.
        Circulation. 2000; 102: 2031-2037
        • The Thrombolysis in Myocardial Infarction (TIMI) trial
        Phase I findings. TIMI study group.
        N Engl J Med. 1985; 312: 932-936
        • van't Hof A.W.
        • Liem A.
        • Suryapranata H.
        • Hoorntje J.C.
        • de Boer M.J.
        • Zijlstra F.
        Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.
        Circulation. 1998; 97: 2302-2306
        • Gibson C.M.
        • Murphy S.A.
        • Morrow D.A.
        • et al.
        Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.
        Am Heart J. 2004; 148: 336-340
        • Schroder R.
        Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction.
        Circulation. 2004; 110: e506-e510
        • Gibson C.M.
        • Karha J.
        • Murphy S.A.
        • et al.
        Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials.
        J Am Coll Cardiol. 2003; 42: 7-16
        • Cutlip D.E.
        • Windecker S.
        • Mehran R.
        • et al.
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Cho K.H.
        • Jeong M.H.
        • Ahmed K.
        • et al.
        Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
        Am J Cardiol. 2011; 107: 849-856
        • Duffy B.K.
        • Gurm H.S.
        • Rajagopal V.
        • Gupta R.
        • Ellis S.G.
        • Bhatt D.L.
        Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.
        Am J Cardiol. 2006; 97: 993-996
        • Azab B.
        • Zaher M.
        • Weiserbs K.F.
        • et al.
        Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction.
        Am J Cardiol. 2010; 106: 470-476
        • Niccoli G.
        • Burzotta F.
        • Galiuto L.
        • Crea F.
        Myocardial no-reflow in humans.
        J Am Coll Cardiol. 2009; 54: 281-292
        • Ozcan F.
        • Karakas M.F.
        • Ozlu M.F.
        • et al.
        Effect of serum gamma-glutamyl transferase levels on myocardial perfusion and long-term prognosis after primary angioplasty in patients with acute ST-elevation myocardial infarction.
        J Investig Med. 2012; 60: 1186-1193
        • Basar N.
        • Sen N.
        • Ozcan F.
        • et al.
        Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
        J Investig Med. 2011; 59: 931-937
        • Basar N.
        • Sen N.
        • Kanat S.
        • et al.
        Lower fetuin-A predicts angiographic impaired reperfusion and mortality in ST-elevation myocardial infarction.
        J Investig Med. 2011; 59: 816-822
        • Sen N.
        • Ozlu M.F.
        • Akgul E.O.
        • et al.
        Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
        Atherosclerosis. 2011; 219: 304-310
        • Siminiak T.
        • Flores N.A.
        • Sheridan D.J.
        Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury.
        Eur Heart J. 1995; 16: 160-170
        • Naruko T.
        • Ueda M.
        • Haze K.
        • et al.
        Neutrophil infiltration of culprit lesions in acute coronary syndromes.
        Circulation. 2002; 106: 2894-2900
        • Avanzas P.
        • Quiles J.
        • Lopez de Sa E.
        • et al.
        Neutrophil count and infarct size in patients with acute myocardial infarction.
        Int J Cardiol. 2004; 97: 155-156
        • Kyne L.
        • Hausdorff J.M.
        • Knight E.
        • Dukas L.
        • Azhar G.
        • Wei J.Y.
        Neutrophilia and congestive heart failure after acute myocardial infarction.
        Am Heart J. 2000; 139: 94-100
        • Kirtane A.J.
        • Bui A.
        • Murphy S.A.
        • Barron H.V.
        • Gibson C.M.
        Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction.
        Am J Cardiol. 2004; 93: 532-536
        • Sezer M.
        • Okcular I.
        • Goren T.
        • et al.
        Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention.
        Heart. 2007; 93: 313-318
        • Dragu R.
        • Khoury S.
        • Zuckerman R.
        • et al.
        Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction.
        Atherosclerosis. 2008; 196: 405-412
        • Nunez J.
        • Nunez E.
        • Bodi V.
        • et al.
        Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction.
        Am J Cardiol. 2008; 101: 747-752
        • Jala V.R.
        • Haribabu B.
        Leukotrienes and atherosclerosis: new roles for old mediators.
        Trends Immunol. 2004; 25: 315-322
        • Ricevuti G.
        • Mazzone A.
        • De Servi S.
        • Specchia G.
        • Fratino P.
        New trends in coronary artery disease: the role of granulocyte activation.
        Atherosclerosis. 1989; 78: 261-265
        • Madjid M.
        • Awan I.
        • Willerson J.T.
        • Casscells S.W.
        Leukocyte count and coronary heart disease: implications for risk assessment.
        J Am Coll Cardiol. 2004; 44: 1945-1956
        • Zouridakis E.G.
        • Garcia-Moll X.
        • Kaski J.C.
        Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris.
        Am J Cardiol. 2000; 86: 449-451
        • Ommen S.R.
        • Gibbons R.J.
        • Hodge D.O.
        • Thomson S.P.
        Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease.
        Am J Cardiol. 1997; 79: 812-814
        • Thomson S.P.
        • McMahon L.J.
        • Nugent C.A.
        Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood.
        Clin Immunol Immunopathol. 1980; 17: 506-514
        • Hotchkiss R.S.
        • Karl I.E.
        The pathophysiology and treatment of sepsis.
        N Engl J Med. 2003; 348: 138-150
        • Gupta S.
        • Agrawal A.
        • Agrawal S.
        • Su H.
        • Gollapudi S.
        A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis.
        Immun Ageing. 2006; 3: 5
        • Blum A.
        • Sclarovsky S.
        • Rehavia E.
        • Shohat B.
        Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction.
        Am Heart J. 1994; 127: 1226-1230
        • Akpek M.
        • Kaya M.G.
        • Lam Y.Y.
        • et al.
        Relation of Neutrophil/Lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
        Am J Cardiol. 2012;
        • Kaya M.G.
        • Akpek M.
        • Lam Y.Y.
        • et al.
        Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
        Int J Cardiol. 2012;
        • Kaya M.G.
        • Arslan F.
        • Abaci A.
        • van der Heijden G.
        • Timurkaynak T.
        • Cengel A.
        Myocardial blush grade: a predictor for major adverse cardiac events after primary PTCA with stent implantation for acute myocardial infarction.
        Acta Cardiol. 2007; 62: 445-451